What this amendment does
The National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 4) 2026 amends the rules that set minimum prices - known as floor prices - for certain brands of pharmaceutical items listed under the National Health Act 1953. The amendment was registered on 31 August 2026 and is administered by the federal Department of Health, Disability and Ageing.
Three-stage structure
The amendment operates in three stages:
- General amendments - take effect as part of the registered determination.
- Additional designated brands (first wave) - take effect from 1 December 2026.
- Further additional designated brands (second wave) - take effect from 1 February 2027.
The source does not specify which pharmaceutical items or brands are affected, or what the floor prices are set at.
Key actions
- Check the full text of the amendment at https://www.legislation.gov.au/F2026N00653 to identify which brands are newly designated and what floor prices apply from 1 December 2026 and 1 February 2027.
- Update dispensing or pricing systems before 1 December 2026 for the first wave of newly designated brands, and again before 1 February 2027 for the second wave.
- Contact the Department of Health, Disability and Ageing for clarification on which specific products are affected by this determination.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.